OTHER GROUP COMPANIES
market

Zydus Lifesciences consolidated net profit declines 11.73% in the June 2022 quarter

Sales rise 0.14% to Rs 3922.90 crore

August 10, 2022 2:29 IST | capital market
Net profit of Zydus Lifesciences declined 11.73% to Rs 518.30 crore in the quarter ended June 2022 as against Rs 587.20 crore during the previous quarter ended June 2021. Sales rose 0.14% to Rs 3922.90 crore in the quarter ended June 2022 as against Rs 3917.40 crore during the previous quarter ended June 2021.
ParticularsQuarter Ended
?Jun. 2022Jun. 2021% Var.
Sales3922.903917.40 0
OPM %21.0223.82 -
PBDT856.30959.70 -11
PBT675.60777.00 -13
NP518.30587.20 -12
Powered by Capital Market - Live News

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000

FEATURED ARTICLE

BLOGS

Open Demat Account
  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity